Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)

50.20 +0.25 (+0.51%)

Streaming Delayed Price Updated: 9:42 AM EDT, Apr 14, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	10,950
Open	50.63
Bid (Size)	49.80 (100)
Ask (Size)	50.60 (300)
Prev. Close	49.95
Today's Range	50.02 - 50.70
52wk Range	29.16 - 59.68
Shares Outstanding	53,145,884
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Unprofitable Stocks We Think Twice About

Today 0:37 EDT

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...

Via StockStory

1 Cash-Producing Stock to Consider Right Now and 2 Facing Headwinds

April 13, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...

Via StockStory

Performance

YTD	+1.5%	+1.5%
1 Month	-0.0%	-0.0%
3 Month	-2.2%	-2.2%
6 Month	+3.8%	+3.8%
1 Year	+58.9%	+58.9%

More News

Supernus Pharma Insider Sells $5.4 Million as Stock Surges 53% in a Year ↗

March 27, 2026

Via The Motley Fool

3 Reasons SUPN is Risky and 1 Stock to Buy Instead

March 12, 2026

Via StockStory

Supernus Pharmaceuticals Inc (NASDAQ:SUPN) Posts Strong Q4 Beat as CNS Portfolio Accelerates Growth ↗

February 24, 2026

Via Chartmill

Supernus Pharmaceuticals’s (NASDAQ:SUPN) Q4 CY2025: Strong Sales

February 24, 2026

Via StockStory

Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results

February 24, 2026

From Supernus Pharmaceuticals, Inc.

Via GlobeNewswire

Supernus Pharmaceuticals to Participate in March Investor Conferences

February 23, 2026

From Supernus Pharmaceuticals, Inc.

Via GlobeNewswire

Supernus Pharmaceuticals (SUPN) To Report Earnings Tomorrow: Here Is What To Expect

February 22, 2026

Via StockStory

Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A

February 17, 2026

Via Investor Brand Network

Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A

February 17, 2026

From BioMedWire

Via GlobeNewswire

3 Reasons to Avoid SUPN and 1 Stock to Buy Instead

February 16, 2026

Via StockStory

Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026

February 12, 2026

From Supernus Pharmaceuticals, Inc.

Via GlobeNewswire

1 Cash-Heavy Stock on Our Buy List and 2 We Brush Off

February 08, 2026

Via StockStory

1 Healthcare Stock to Consider Right Now and 2 We Brush Off

January 28, 2026

Via StockStory

2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds

January 25, 2026

Via StockStory

3 Unprofitable Stocks We Steer Clear Of

January 21, 2026

Via StockStory

A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗

January 15, 2026

Via Chartmill

Regencell Bioscience (RGC) Stumbles into 2026: 8% Year-End Slide Sparks Technical Caution

January 01, 2026

Via MarketMinute

3 Low-Volatility Stocks We’re Skeptical Of

December 31, 2025

Via StockStory

3 of Wall Street’s Favorite Stocks That Concern Us

December 22, 2025

Via StockStory

Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order ↗

December 19, 2025

Via Stocktwits

Supernus Stock Is Up 31% This Past Year but Still 20% Below 2018 Highs as One Fund Scales Back ↗

December 15, 2025

Via The Motley Fool

1 Cash-Heavy Stock for Long-Term Investors and 2 We Turn Down

December 14, 2025

Via StockStory

3 Stocks Under $50 That Concern Us

December 11, 2025

Via StockStory

Frequently Asked Questions

Is Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?

Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market

What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?

The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 50.20

When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 04/14/26 09:42 AM ET

What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.67B

How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?

Supernus Pharmaceuticals, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.